Biotech Blueprint

By Katerina Roznik

Connecting with biotech, pharma, and academic professionals to explore the latest in science, startups, market trends, and breakthroughs.

For more content, please subscribe to biotechblueprint.substa... more

· Technology

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Biotech Blueprint:

How many episodes does Biotech Blueprint have?

The podcast currently has 42 episodes available.

Biotech Blueprint episodes:

February 20, 2026 FDA Shifts to One Pivotal Trial and Moderna Flu Shot Back Under FDA Review – This Week in Biotech #90
Subscribe to Biotech Blueprint for free at biotechblueprint.com.

...more
6min
February 06, 2026 Hims Launches Compounded GLP-1 Pill, CVS Forces Biosimilars – This Week in Biotech #88
Compounded semaglutide draws FDA scrutiny as Novo Nordisk guides 2026 lower and Eli Lilly leans into a $50 Medicare copay (Jan 30-Feb 5, 2026).

Follow Biotech Blueprint at biotechblueprint.com.
...more
7min
January 30, 2026 Regenxbio FDA Hold, Sanofi Vaccine Demand Softness, and CMS Negotiation Expansion – This Week in Biotech #87
FDA pauses two AAV programs, Sanofi reports US vaccine uptake slipping, and CMS widens negotiations to more blockbuster drugs (Jan 23-29, 2026).

Subscribe to Biotech Blueprint at biotechblueprint.com.
...more
8min
January 23, 2026 Moderna Merck V940 Shows Five Year Melanoma Durability, Biopharma Deal Activity Picks Up
This Week in Biotech #86. Subscribe to Biotech Blueprint for free at biotechblueprint.com.
KEYNOTE-942 durability, plus GSK’s $2.2B RAPT food allergy deal, BMS partners with Janux, Corcept's overall survival win, and Corvus posts Phase 1 eczema data (Jan 16-22, 2026).
...more
8min
January 09, 2026 #CDC #Vaccine Schedule Shifts, Practice-Changing Phase 3 Wins, and Deal Heat – This Week in Biotech #84
Subscribe to This Week in Biotech for free at biotechblueprint.com.
...more
8min
December 10, 2025 Inside NImmune’s Phase 3 Push in Ulcerative Colitis
I sat down with NImmune CEO Josep Bassaganya-Riera to talk about omilancor, their gut-restricted oral IBD drug now in Phase 3 clinical trials. We cover LANCL2 biology, their biomarker aimed at boosting response rates, and the TITAN-X platform that helps guide real development decisions. A really interesting look at how you build an oral immunology company in 2025.Follow Biotech Blueprint for free at https://www.biotechblueprint.com/NImmune Biopharma: https://nimmunebio.com/Josep's LinkedIn profile: https://www.linkedin.com/in/josep-bassaganya-riera/ Connect with me on LinkedIn: https://www.linkedin.com/in/katerina-roznik/
...more
34min
December 10, 2025 FDA Tightens Vaccine Pathways, Medicare Slashes Drug Prices — This Week in Biotech #80
Plus Duchenne’s landmark phase 3 win, a survival boost in glioblastoma, motion sickness momentum at Vanda, and ACIP’s newborn vaccine chaos (Nov 21-Dec 4, 2025).
Subscribe to Biotech Blueprint for free at biotechblueprint.com.
...more
6min
November 24, 2025 CDC’s Autism Reversal Shocks Experts, mRNA Flu Shot Advances, Big Oncology Wins - This Week in Biotech #79
Subscribe to Biotech Blueprint at biotechblueprint.com
...more
7min
November 14, 2025 FDA Opens New Pathway, Pfizer’s $10B GLP-1 Win, and Biotech’s Return to Offense — This Week in Biotech #78
Subscribe to Biotech Blueprint for free at biotechblueprint.com.

A week of rare regulatory momentum, strategic M&A, and meaningful clinical wins.
...more
8min
November 13, 2025 Inside Sensible Biotechnologies: Reinventing mRNA Manufacturing
Subscribe to Biotech Blueprint at biotechblueprint.com In today's episode:How an Oxford-born, YC-backed startup is betting that cell-based production will define mRNA’s next decade.
...more
52min

FAQs about Biotech Blueprint:

How many episodes does Biotech Blueprint have?

The podcast currently has 42 episodes available.